An overview of thyroid eye disease

scientific article

An overview of thyroid eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1017518179
P356DOI10.1186/S40662-014-0009-8
P932PMC publication ID4655452
P698PubMed publication ID26605355
P5875ResearchGate publication ID269420715

P2093author name stringColm McAlinden
P2860cites workClassification of the Eye Changes of Graves' DiseaseQ67908768
Pathogenesis of Graves' ophthalmopathyQ70513409
Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinicQ72800952
Management of exophthalmos and related ocular changes in Graves' diseaseQ74338185
Thyroid eye diseaseQ83446693
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the futureQ24673258
Acute thyroid eye disease (TED): principles of medical and surgical managementQ26827429
Selenium and the course of mild Graves' orbitopathyQ28238021
Graves' ophthalmopathyQ28274196
Clinical features of Graves' ophthalmopathy in an incidence cohortQ28275743
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approachQ33647383
Immunopathogenesis of thyroid eye disease: emerging paradigmsQ33789467
Orbital radiotherapy for Graves' ophthalmopathyQ34599785
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL.Q35305938
Thyroid associated orbitopathy.Q35919247
Risk factors for development or deterioration of Graves' ophthalmopathyQ35975724
Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.Q36070800
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchersQ36568033
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.Q37017174
Thyroid eye disease: pathogenesis and treatmentQ37639036
Optimal management of Graves orbitopathy: a multidisciplinary approach.Q37936059
Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.Q38013212
Smoking and thyroidQ38098569
Quality assessment of ophthalmic questionnaires: review and recommendationsQ38123064
Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathyQ39570204
Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?Q40678838
Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunityQ42529169
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidismQ43907362
Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid diseaseQ45282049
Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.Q48583277
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjecteye diseaseQ3041498
P304page(s)9
P577publication date2014-12-10
P1433published inEye and vision (London, England)Q27726793
P1476titleAn overview of thyroid eye disease
P478volume1

Reverse relations

cites work (P2860)
Q46835363Effect of smoking on retrobulbar blood flow in thyroid eye disease
Q58767198Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results
Q91653026Review of thyroid eye disease in euthyroid state with periocular mucinosis
Q90574553The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran

Search more.